Tracheobronchopathy From Inhaled Corticosteroids.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 28864055.
- Also identified by DOI 10.1016/j.chest.2017.08.013 and PMC identifier 6026226.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Inhaled corticosteroids (ICSs) have become the mainstay of asthma control. They are also recommended as an add-on therapy to long-acting beta agonists and anticholinergics in moderate to severe COPD with recurrent exacerbations. Ultimately this clinical practice has led to the widespread use of ICSs, which are supported by a more favorable side effect profile than that of systemic steroids.
Medical subject headings
- Adrenal Cortex Hormones
- Asthma
- Bronchial Diseases
- Tracheal Diseases